Filing Details

Accession Number:
0001209191-13-024590
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-07 16:30:10
Reporting Period:
2013-05-03
Filing Date:
2013-05-07
Accepted Time:
2013-05-07 16:30:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1190290 Elaine Ullian C/O Vertex Pharmaceuticals Incorporated
130 Waverly St.
Cambridge MA 02139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-03 20,000 $29.84 25,265 No 4 M Direct
Common Stock Acquisiton 2013-05-03 20,000 $29.89 45,265 No 4 M Direct
Common Stock Disposition 2013-05-03 40,000 $77.99 5,265 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2013-05-03 20,000 $0.00 20,000 $29.84
Common Stock Stock Option (right to buy) Disposition 2013-05-03 20,000 $0.00 20,000 $29.89
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-05-31 No 4 M Direct
0 2019-05-31 No 4 M Direct
Footnotes
  1. Open market sales reported on this line occurred at a weighted average price of $77.99 (range $77.95 to $78.15).
  2. Ms. Ullian undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  3. Fully vested.